These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8465275)

  • 21. A recombinant hirudin (IK-HIR02) in healthy volunteers. I. Effects on coagulation parameters and bleeding time.
    Schenk JF; Glusa E; Radziwon P; Butti A; Markwardt F; Breddin HK
    Haemostasis; 1996; 26(3):140-9. PubMed ID: 8738588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacology of recombinant hirudin.
    Markwardt F; Nowak G; Stürzebecher J
    Haemostasis; 1991; 21 Suppl 1():133-6. PubMed ID: 1894188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis.
    Schiele F; Vuillemenot A; Kramarz P; Kieffer Y; Soria J; Soria C; Camez A; Mirshahi MC; Bassand JP
    Thromb Haemost; 1994 May; 71(5):558-62. PubMed ID: 8091380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation on recombinant hirudin via oral route.
    Cen X; Ni J; Tan T; Liu X; Li C; Chen J; Huang Y; Zhu S; Bi Q
    Peptides; 2006 Apr; 27(4):836-40. PubMed ID: 16469415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Degradation of recombinant hirudin-2 in nasal mucosa of rabbits in vitro].
    Zhang YJ; Wu JM; Zhang Q; Chen MX; Sun WJ
    Yao Xue Xue Bao; 2006 Nov; 41(11):1099-103. PubMed ID: 17262955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and partial thromboplastin time after intravenous recombinant hirudin variant-2 in rhesus monkeys.
    Liu XW; Song HF; Tang ZM; Zhao K; Zhu BZ; Wang LP; Zhang Y
    Acta Pharmacol Sin; 2002 Sep; 23(9):842-6. PubMed ID: 12230955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of rec-hirudin in healthy volunteers after intravenous administration.
    Cardot JM; Lefèvre GY; Godbillon JA
    J Pharmacokinet Biopharm; 1994 Apr; 22(2):147-56. PubMed ID: 7815310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of recombinant hirudin in healthy horses.
    Feige K; Dennler M; Kästner SB; Wunderli-Allenspach H; Demuth D; Huber A
    Equine Vet J; 2004 Mar; 36(2):135-41. PubMed ID: 15038436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of hirudin in man after single subcutaneous and intravenous bolus administration.
    Bichler J; Fichtl B; Siebeck M; Fritz H
    Arzneimittelforschung; 1988 May; 38(5):704-10. PubMed ID: 3415713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics study of recombinant hirudin in the plasma of rats using chromogenic substrate, ELISA, and radioisotope assays.
    Jiang SY; Jiao J; Zhang TT; Xu YP
    PLoS One; 2013; 8(6):e64336. PubMed ID: 23785400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New anticoagulant protein from medicinal leech.
    Manuvera VA; Kharlampieva DD; Bobrovsky PA; Grafskaia EN; Brovina KA; Lazarev VN
    Biochem Biophys Res Commun; 2024 Feb; 696():149473. PubMed ID: 38241814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of a long-acting recombinant hirudin (PEG-hirudin) on experimental disseminated intravascular coagulation (DIC) in rabbits.
    Zawilska K; Zozulinska M; Turowiecka Z; Blahut M; Drobnik L; Vinazzer H
    Thromb Res; 1993 Feb; 69(3):315-20. PubMed ID: 8475480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic studies with recombinant hirudin in dogs.
    Nowak G; Markwardt F; Fink E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):70-4. PubMed ID: 2459035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant hirudin (HBW 023): biological data of ten patients with severe venous thrombo-embolism.
    Bridey F; Dreyfus M; Parent F; Bros A; Fischer AM; Camez A; Simonneau G; Duroux P; Meyer D
    Am J Hematol; 1995 May; 49(1):67-72. PubMed ID: 7741141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology of recombinant hirudin.
    Nowak G
    Semin Thromb Hemost; 2002 Oct; 28(5):415-24. PubMed ID: 12420236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hirudins: from leeches to man.
    Wallis RB
    Semin Thromb Hemost; 1996; 22(2):185-96. PubMed ID: 8807716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant hirudin in patients with chronic, stable coronary artery disease. Safety, half-life, and effect on coagulation parameters.
    Zoldhelyi P; Webster MW; Fuster V; Grill DE; Gaspar D; Edwards SJ; Cabot CF; Chesebro JH
    Circulation; 1993 Nov; 88(5 Pt 1):2015-22. PubMed ID: 8222093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential use of recombinant hirudin as an anticoagulant in a cardiopulmonary bypass model.
    Walenga JM; Bakhos M; Messmore HL; Fareed J; Pifarre R
    Ann Thorac Surg; 1991 Feb; 51(2):271-7. PubMed ID: 1989543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacology of intravenously administered recombinant desulfatohirudin (CGP 39393) in healthy volunteers.
    Marbet GA; Verstraete M; Kienast J; Graf P; Hoet B; Tsakiris DA; Silling-Engelhardt G; Close P
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):364-72. PubMed ID: 7504125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aptamer-thrombin loaded magnetic microspheres for bio-specific extraction and precise detection of hirudin.
    Cao X; Luo Y; Liu X; Shang C; Lu J; Song G; Deng C
    Talanta; 2024 Jan; 267():125244. PubMed ID: 37757694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.